Mitochondrial Disorder Aggravated by Metoprolol
Beta-adrenergic blocking agents or beta-blockers are a class of medications used to treat cardiac arrhythmias and systemic hypertension. In therapeutic dosages, they have known adverse outcomes that can include muscular fatigue and cramping, dizziness, and dyspnea. In patients with mitochondrial dis...
Saved in:
Main Authors: | Cheryl Samuels, Mary Kay Koenig, Mariana Hernandez, Aravind Yadav, Ricardo A. Mosquera |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2016/7869174 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sleep Disordered Breathing in Children with Mitochondrial Disease
by: Ricardo A. Mosquera, et al.
Published: (2014-01-01) -
Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
by: S. Serge Barold, et al.
Published: (2018-01-01) -
Chitosan-multilayered graphene oxide hybrid beads for $\protect \text{Zn}^{2+}$ and metoprolol adsorption
by: Bouyahmed, Farida, et al.
Published: (2022-09-01) -
Therapies for Mitochondrial Disorders
by: Kayli Sousa Smyth, et al.
Published: (2022-12-01) -
Screening Children with a Family History of Central Congenital Hypoventilation Syndrome
by: Hina Emanuel, et al.
Published: (2020-01-01)